The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRC-2 epigenetic chromatin reprogramming in ALK-positive (ALK+) lung cancer initial emergence of precision drug resistance.
 
Patrick C. Ma
Stock and Other Ownership Interests - Cymeta Biopharmaceutical
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); Cymeta Biopharmaceutical (Inst); EpicentRx (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst); Tesaro (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Xiaoliang Wu
No Relationships to Disclose
 
Satoshi Komo
No Relationships to Disclose
 
Zuan-Fu Lim
No Relationships to Disclose
 
Haixia Yang
No Relationships to Disclose
 
Kacey Rhodes
No Relationships to Disclose
 
Brandon C. Jones
No Relationships to Disclose
 
Daniel J. Lindner
No Relationships to Disclose
 
Francisco Almeida
No Relationships to Disclose
 
Veronique Neumeister
Employment - Indivumed
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Foundation Medicine; Genentech; Genoptix; Merck; Takeda
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Foundation Medicine; Merck
 
Elena Pugacheva
No Relationships to Disclose
 
Ivan Martinez
No Relationships to Disclose
 
Lihong Yin
No Relationships to Disclose
 
Sijin Wen
No Relationships to Disclose
 
Zhenfeng Zhang
No Relationships to Disclose